| 英文别名 |
Saquinavir mesylate;Saquinavir (mesylate);003;Ro 31-8959;Saquinavir mesilate;(2S)-N1[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-Dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]butanediamide methanesulfonate;Ro-31-8959;INVIRASE;MESYLATE;Ro 31-895;FORTOVASE;Methanesulfonate salt;SAQUINAVIR MESYLATE PH.EUR;Saquinavir Mesylate (200 mg);Saquinavir, Mesylate;Saquinavir monomethanesulfonate salt;UHB9Z3841A;Saquinavir mesylate (AIDS Initiative);DSSTox_CID_3835;DSSTox_RID_77202;DSSTox_GSID_23835;(S)-N-((alphaS)-alpha-((1R)-2-((3S,4aS,8aS)-3-(tert-Butylcarbamoyl)octahydro-2(1H)-isoquinolyl)-1-hydroxyethyl)phenethyl)-2-quinaldamidosuccinamide monomethanesulfonate (salt);Butanediamide, N1-((1S,2R;Ro 31-8959/003;N-t-butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl)-L-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide methanesulphonate;SAQUINAVIR MESYLATE [VANDF];Butanediamide, N(sup 1)-(3-(3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1H)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (3S-(2(1R*(R*),2S*),3alpha,4abeta,8abeta))-, monomethanesulfonate (salt);Tox21_202533;(S)-N-((alphaS)-alpha-((1R)-2-((3S,4AS,8AS)-3-(TERT-BUTYLCARBAMOYL)OCTAHYDRO-2(1H)-ISOQUINOLYL)-1-HYDROXYETHYL)PHENETHYL)-2-QUINALDAMIDOSUCCINAMIDE MONOMETHANESULPHONATE;149845-06-7;HMS1571O10;SAQUINAVIR MESILATE (EP MONOGRAPH);Invirase (TN);Butanediamide, N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-, (2S)-, methanesulfonate (1:1);SAQUINAVIR MESYLATE [USP MONOGRAPH];SAQUINAVIR MESYLATE (USP-RS);Butanediamide, N1-((1S,2R)-3-((3S,4aS,8aS)-3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1H)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (2S)-, monomethanesulfonate (salt);SAQUINAVIR MESILATE [EP MONOGRAPH];(S)-N1-((2S,3R)-4-((3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-phenylbutan-2-yl)-2-(quinoline-2-carboxamido)succinamide methanesulfonate;(S)-N-((.ALPHA.S)-.ALPHA.-((1R)-2-((3S,4AS,8AS)-3-(TERT-BUTYLCARBAMOYL)OCTAHYDRO-2(1H)-ISOQUINOLYL)-1-HYDROXYETHYL)PHENETHYL)-2-QUINALDAMIDOSUCCINAMIDE MONOMETHANESULFONATE;BS164392;HMS2231C15;127779-20-8 (base);SAQUINAVIR MESYLATE [USP-RS];Saquinavir mesylate, >=98% (HPLC), powder;Ro-318959003;CAS-149845-06-7;Tox21_111137;NCGC00260082-01;Ro-31-8959/003;Saquinavir mesilate, European Pharmacopoeia (EP) Reference Standard;(2S)-N1[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-Dimethylethyl)amino]carbonyl]octahydro-2-(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]butanediamide Mesylate;KS-1110;NCGC00091469-01;AKOS015962362;F84902;Saquinavir mesylate, United States Pharmacopeia (USP) Reference Sta... |